Rebecca Lamb-Wharton, Ph.D., serves as Principal Scientist, Regulatory Affairs and Product Development, for Cardinal Health Regulatory Sciences. She provides leadership, development, and execution of regulatory and clinical strategies across a broad range of drug and combination product modalities and therapeutic areas. She provides scientific and regulatory consulting activities from IND submission and maintenance to product approval of NDAs with post-marketing activities. She provides regulatory insights and management of FDA applications while serving as U.S. agent. She is responsible for the preparation and review of administrative, regulatory, labeling, and clinical documents with over 22 years of experience in the pharmaceutical industry.